| Literature DB >> 29345168 |
Jessika Moreau1,2, Nicolas Gatimel1,2, Clémentine Cohade1, Jean Parinaud1,2, Roger Léandri1,2.
Abstract
To detect clinical parameters impacting ovarian reserve, data were analyzed from 573 patients who had an anti-Müllerian hormone (AMH) measurement for infertility treatment. No impact was found on the age at menarche but a significant diminished ovarian reserve was observed when a patient's mother was menopausal before age 50. These data suggest that ovarian reserve must be monitored in such patients to offer them fertility preservation when at risk of premature ovarian insufficiency (POI).Entities:
Keywords: AMH; menarche; menopause; premature ovarian insufficiency
Mesh:
Substances:
Year: 2018 PMID: 29345168 DOI: 10.1080/09513590.2018.1428300
Source DB: PubMed Journal: Gynecol Endocrinol ISSN: 0951-3590 Impact factor: 2.260